These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16735336)

  • 21. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neglected issue in interpretation of results of randomized controlled trials: informative censoring.
    Gorouhi F; Khatami A; Davari P
    Dermatol Online J; 2009 Jan; 15(1):13. PubMed ID: 19281718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meta-analyses--statistical alchemy of the 21st century?].
    Kristiansen IS
    Tidsskr Nor Laegeforen; 2000 Sep; 120(22):2615. PubMed ID: 11077501
    [No Abstract]   [Full Text] [Related]  

  • 27. Covariate adjustment increases statistical power in randomized controlled trials.
    Lingsma H; Roozenbeek B; Steyerberg E;
    J Clin Epidemiol; 2010 Dec; 63(12):1391; author reply 1392-3. PubMed ID: 20800991
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial.
    Putter H; Sasako M; Hartgrink HH; van de Velde CJ; van Houwelingen JC
    Stat Med; 2005 Sep; 24(18):2807-21. PubMed ID: 16134134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of hemodialysis, hemodiafiltration, and hemofiltration: systematic review or systematic error?
    Locatelli F
    Am J Kidney Dis; 2005 Oct; 46(4):787-8; author reply 788-9. PubMed ID: 16183439
    [No Abstract]   [Full Text] [Related]  

  • 30. Statistical reanalysis of a randomized trial of acupuncture for pain reveals positive effects as well as adverse treatment interactions on pain, attrition, and mortality.
    Shiflett SC; Schwartz GE
    Explore (NY); 2010; 6(4):246-55. PubMed ID: 20633839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
    Gray RJ
    Biometrics; 1994 Mar; 50(1):244-53. PubMed ID: 8086608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis and adverse drug reactions.
    Mittmann N; Liu BA; Knowles SR; Shear NH
    CMAJ; 1999 Apr; 160(7):987-8. PubMed ID: 10207335
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential meta-analysis of single-case experimental data.
    Kuppens S; Heyvaert M; Van den Noortgate W; Onghena P
    Behav Res Methods; 2011 Sep; 43(3):720-9. PubMed ID: 21455830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.
    Furukawa TA; Watanabe N; Omori IM; Montori VM; Guyatt GH
    JAMA; 2007 Feb; 297(5):468-70. PubMed ID: 17284696
    [No Abstract]   [Full Text] [Related]  

  • 35. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretation of randomised trials is indeed open to debate.
    Conradi P; Taylor D
    BMJ; 2003 Sep; 327(7417):752. PubMed ID: 14512497
    [No Abstract]   [Full Text] [Related]  

  • 37. Forest plots.
    Verhagen AP; Ferreira ML
    J Physiother; 2014 Sep; 60(3):170-3. PubMed ID: 25084633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical analysis of ordinal categorical status after therapies.
    Grissom RJ
    J Consult Clin Psychol; 1994 Apr; 62(2):281-4. PubMed ID: 8201065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open access follow up for inflammatory bowel disease. Would have been better to use t test than Mann-Whitney U test.
    Barber JA; Thompson SG
    BMJ; 2000 Jun; 320(7251):1730; author reply 1730-1. PubMed ID: 10917710
    [No Abstract]   [Full Text] [Related]  

  • 40. Subgroup analyses: how to avoid being misled.
    Fletcher J
    BMJ; 2007 Jul; 335(7610):96-7. PubMed ID: 17626964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.